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ferentiated, tightly ensheathing all axons and forming insulating
myelin sheaths around the larger ones. Nerve injury triggers a
radical change in these cells: They start to proliferate, the myelin
sheaths collapse and are phagocytosed and digested by Schwann
cells and macrophages and Schwann cells start expressing a
range of molecules that promote neuronal survival and axon
growth. Overall this represents a process of de-differentiation,
because this injury-response takes the differentiated cells of
normal nerves back to a phenotype that is very similar to that of
immature Schwann cells found in developing nerves prior to
myelination. Remarkably, this de-differentiation process is the
basis for the ability of axons to regenerate after injury, and when
it is prevented axon re-growth is blocked or severely impaired.
The molecular processes responsible for the de-differentiation are
therefore fundamental for nerve repair. This talk will discuss
some of the molecules that control the de-differentiation pro-
gramme, in particular the transcription factor c-Jun and the sig-
nalling receptor Notch. It will describe how molecular failures
within this programme result in failure of axon regeneration and
functional nerve recovery.
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Magnetic Resonance Imaging (MRI) is one of the most powerful
tools for high-resolution, non-invasive imaging. Apart from mon-
itoring anatomical changes and functional recovery, the location
and potentially functional changes of cells can be followed by
MRI. It has recently been demonstrated that the migration of low
cell numbers can be monitored in rodents after cell labeling with
MRI contrast agents and subsequent implantation.
We have focused on methodological aspects of cell labelling
strategies for robust and sensitive visualisation of multipotent adult
progenitor cells, mesenchymal stem cells and embryonic stem
cells. The sensitivity, stability, toxicity and adverse effects on the
cell biology by the labelling procedure was studied for ultrasmall,
small and micron-sized iron oxide particles. In vivo imaging was
performed in control animals and a stroke animal model.
Although, the actual labelling procedure can be straight forward,
there are several issues that require careful consideration for (stem)
cell labelling and their in vivo applications. Among these issues
are:
(1) Generation of highly sensitive contrast for the visualization
of small cell numbers
(2) Generation of unambiguous contrast that distinguishes cells
from other sources of hypo- or hyperintensity in MR images
(3) Stable binding or incorporation to avoid contrast agent
leakage or transfer to cells of the host
(4) Prevention of toxicity or harmful alterations of cellular
processes by the contrast agent
(5) Minimal inﬂuence on the physiological behavior of the cells
in the host (for example migration of differentiation potential)
(6) Generation of contrast even after continued cell proliferation
(dilution)
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In tissue engineering, scaffolds development presents, among
others, 3 key requirements: adequate morphological characteristics,
mechanical performance and in-vivo biocompatibility. The aim of
the present study was to evaluate chitosan-based scaffolds produced
by particle aggregation in these key issues. Furthermore, chitosan
scaffolds were loaded with insulin to promote chondrogenic dif-
ferentiation. Micro-Computed Tomography (m-CT) was carried out
for accurate morphometric characterization quantifying porosity,
interconnectivity, particles and pores size that shown to be ade-
quate. Dynamical Mechanical Analysis (DMA) showed that scaf-
folds are mechanically stable in wet state with a storage modulus
of 4.21 1.04MPa at 1Hz frequency. Insulin-loaded scaffolds
were characterized and studied with a pre-chondrogenic cell line
(ATDC-5). The in-vitro release was carried out mimicking cell
culture conditions quantiﬁed by micro-BCA. When seeded with
ATDC-5, insulin-loaded scaffolds promoted the chondrogenic dif-
ferentiation as assessed by SEM, DNA and GAG content, histology
and real time-PCR. Furthermore, chitosan scaffolds were evaluated
in-vivo using a rat muscle-pockets defect model for different
implantation periods (1, 2 and 12 weeks). The histological and im-
munohistochemistry results have demonstrated that chitosan scaf-
folds are biocompatible. In addition, scaffolds interconnectivity
shown to be favourable to the connective tissues ingrowth into the
scaffolds and to promote the neo-vascularization even in early stages
of implantation. It is concluded that chitosan scaffolds produced by
particle aggregation could serve as alternative, biocompatible, and
safe biodegradable scaffolds for tissue engineering applications.
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The aim of this study was the scaling-up of mouse embryonic stem
(mES) cell expansion in a microcarrier-based stirred culture system
while maintaining their pluripotency and neural commitment po-
tential. The 46C mES cell line was used as a model system. The
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